{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T13:51:44Z","timestamp":1675864304935},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,7,15]],"date-time":"2010-07-15T00:00:00Z","timestamp":1279152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s00535-010-0283-8","type":"journal-article","created":{"date-parts":[[2010,7,14]],"date-time":"2010-07-14T05:58:07Z","timestamp":1279087087000},"page":"1219-1227","source":"Crossref","is-referenced-by-count":8,"title":["A double-blind, controlled study comparing lafutidine with placebo and famotidine in Japanese patients with mild reflux esophagitis"],"prefix":"10.1007","volume":"45","author":[{"given":"Shuichi","family":"Ohara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Haruma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoyasu","family":"Kusano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,15]]},"reference":[{"key":"283_CR1","first-page":"1010","volume":"102","author":"S Ohara","year":"2005","unstructured":"Ohara S, Kouzu T, Kawano T, Kusano M. Nationwide epidemiological survey regarding hertburn and reflux esophagitis in Japanese (in Japanese with English abstract). Nippon shokakibyo Gakkai Zasshi (JSSG). 2005;102:1010\u201324.","journal-title":"Nippon shokakibyo Gakkai Zasshi (JSSG)"},{"key":"283_CR2","first-page":"CD003244","volume":"18","author":"M Khan","year":"2007","unstructured":"Khan M, Santana J, Donnellan C, Preston C, Moayyedi P. Medical treatments in the short term management of reflux oesophagitis. Cochrane database Syst Rev. 2007;18:CD003244.","journal-title":"Cochrane database Syst Rev"},{"key":"283_CR3","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/S0140-6736(06)68932-0","volume":"367","author":"P Moayyedi","year":"2006","unstructured":"Moayyedi P, Talley NJ. Gastro-oesophageal reflux disease. Lancet. 2006;367:2086\u2013100.","journal-title":"Lancet"},{"key":"283_CR4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1440-1746.2000.02131.x","volume":"15","author":"K Haruma","year":"2000","unstructured":"Haruma K, Kamada T, Kawaguchi H, Okamoto S, Yoshihara M, Sumii K, et al. Effect of age and Helicobacter pylori infection on gastric acid secretion. J Gastroenterol Hepatol. 2000;15:277\u201383.","journal-title":"J Gastroenterol Hepatol"},{"key":"283_CR5","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1053\/gast.1996.v110.pm8612992","volume":"110","author":"M Feldman","year":"1996","unstructured":"Feldman M, Cryer B, Mcarthur KE, Huet BA, Lee E. Effects of aging and gastritis on gastric acid and pepsin secretion in humans: a prospective study. Gastroenterology. 1996;110:1043\u201352.","journal-title":"Gastroenterology"},{"key":"283_CR6","first-page":"3","volume":"38","author":"K Fujimoto","year":"2003","unstructured":"Fujimoto K, Iwakiri R, Okamoto K, Oda K, Tanaka A, Tsunada S, et al. Characteristics of gastroesophageal reflux disease in Japan: increased prevalence in elderly women. J Gastroenterol. 2003;38:3\u20136.","journal-title":"J Gastroenterol"},{"key":"283_CR7","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00535-009-0047-5","volume":"44","author":"Y Fujiwara","year":"2009","unstructured":"Fujiwara Y, Arakawa T. Epidemiology and clinical characteristics of GERD in the Japanese population. J Gastroenterol. 2009;44:518\u201334.","journal-title":"J Gastroenterol"},{"key":"283_CR8","first-page":"1280","volume":"54","author":"T Koike","year":"2007","unstructured":"Koike T, Ohara S, Sekine H, Kawamura M, Abe Y, Inomata Y, et al. Effect of Helicobacter pylori status on intragastric pH during administration of lafutidine or famotidine. Hepatogastroenterology. 2007;54:1280\u20134.","journal-title":"Hepatogastroenterology"},{"key":"283_CR9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s10620-006-3094-2","volume":"51","author":"T Shimatani","year":"2006","unstructured":"Shimatani T, Inoue M, Kuroiwa T, Xu J, Nakamura M, Tazuma S, et al. Lafutidine, a newly developed antiulcer drug, elevates postprandial intragastric pH and increases plasma calcitonin gene-related peptide and somatostatin concentrations in humans: comparisons with famotidine. Dig Dis Sci. 2006;51:114\u201320.","journal-title":"Dig Dis Sci"},{"key":"283_CR10","first-page":"588","volume":"107","author":"S Ohara","year":"2010","unstructured":"Ohara S, Haruma K, Kinoshita Y, Kusano M. Efficacy evaluation of Lafutidine for mild reflux esophagitis in Japanese patients (in Japanese with English abstract). Nippon Shokakibyo Gakkai Zasshi (JSSG). 2010;107:588\u201397.","journal-title":"Nippon Shokakibyo Gakkai Zasshi (JSSG)"},{"key":"283_CR11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0028-1098086","volume":"3","author":"K Kimura","year":"1969","unstructured":"Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy. 1969;3:87\u201397.","journal-title":"Endoscopy"},{"key":"283_CR12","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00228-006-0171-6","volume":"62","author":"C Sakamoto","year":"2006","unstructured":"Sakamoto C, Sugano K, Ota S, Sakaki N, Takahashi S, Yoshida Y, et al. Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflamatory drugs in Japan. Eur J Clin Pharmacol. 2006;62:765\u201372.","journal-title":"Eur J Clin Pharmacol"},{"key":"283_CR13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bpg.2010.02.005","volume":"24","author":"R Tutuian","year":"2010","unstructured":"Tutuian R. Clinical lead outpatient services and gastrointestinal function laboratory. Adverse effects of drugs on the esophagus. Best Pract Res Clin Gastroenterol. 2010;24:91\u20137.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"283_CR14","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1365-2036.2008.03821.x","volume":"28","author":"P Ruszniewski","year":"2008","unstructured":"Ruszniewski P, Soufflet C, Barthelemy P. Nonsteroidal anti-inflammatory drug use as a risk factor for gastro-oesophageal reflux disease: an observational study. Aliment Pharmacol Ther. 2008;28:1134\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"283_CR15","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1503\/cmaj.082001","volume":"180","author":"DN Juurlink","year":"2009","unstructured":"Juurlink DN, Gomes T, Ko DT, Szmitko PE, Austin PC, Tu JV, Henry DA, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ. 2009;180:713\u20138.","journal-title":"CMAJ"},{"key":"283_CR16","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1046\/j.1440-1746.2001.02617.x","volume":"16","author":"K Adachi","year":"2001","unstructured":"Adachi K, Fujishiro H, Katsube T, Yuki M, Ono M, Kawamura A, et al. Predominant nocturnal acid reflux in patients with Los Angeles grade C and D reflux esophagitis. J Gastroenterol Hepatol. 2001;16:1191\u20136.","journal-title":"J Gastroenterol Hepatol"},{"key":"283_CR17","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00535-008-2186-5","volume":"43","author":"M Hongo","year":"2008","unstructured":"Hongo M, Kinoshita Y, Haruma K. A randomized, double-blind, placebo-controlled clinical study of the histamine H2-receptor antagonist famotidine in Japanese patients with nonerosive reflux disease. J Gastroenterol. 2008;43:448\u201356.","journal-title":"J Gastroenterol"},{"key":"283_CR18","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1440-1746.2005.03917.x","volume":"20","author":"K Adachi","year":"2005","unstructured":"Adachi K, Komazawa Y, Mihara T, Azumi T, Fujisawa T, Katsube T, et al. Comparative study of the speed of acid-suppressing effects of oral administration of cimetidine and famotidine. J Gastroenterol Hepatol. 2005;20:1012\u20135.","journal-title":"J Gastroenterol Hepatol"},{"key":"283_CR19","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.3748\/wjg.14.2406","volume":"14","author":"H Yamagishi","year":"2008","unstructured":"Yamagishi H, Koike T, Ohara S, Horii T, Kikuchi R, Kobayashi S, et al. Stronger inhibition of gastric acid secretion by lafutidine, a novel H2 receptor antagonist, than by the proton pump inhibitor lansoprazole. World J Gastroenterol. 2008;14:2406\u201310.","journal-title":"World J Gastroenterol"},{"key":"283_CR20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00535-005-1569-0","volume":"40","author":"M Inamori","year":"2005","unstructured":"Inamori M, Togawa J, Iwasaki T, Ozawa Y, Kikuchi T, Muramatsu K, et al. Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use? J Gastroenterol. 2005;40:453\u20138.","journal-title":"J Gastroenterol"},{"key":"283_CR21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-2036.2007.03545.x","volume":"27","author":"T Suzuki","year":"2008","unstructured":"Suzuki T, Yamaguchi T, Odaka T, Kobayashi M, Seza A, Kouzu T. Four-day continuous gastric pH monitoring following anti-acid secretory drug administration: cross-over test to assess the early effects. Aliment Pharmacol Ther. 2008;27:66\u201371.","journal-title":"Aliment Pharmacol Ther"},{"key":"283_CR22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2036.1994.tb00162.x","volume":"8","author":"TJ Simon","year":"1994","unstructured":"Simon TJ, Berenson MM, Berlin RG, Snapinn S, Cagliola A. Randomized, placebo-controlled comparison of famotidine 20\u00a0mg b.d. or 40\u00a0mg b.d. in patients with erosive oesophagitis. Aliment Pharmacol Ther. 1994;8:71\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"283_CR23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.0953-0673.1996.00373.x","volume":"10","author":"MT Silver","year":"1996","unstructured":"Silver MT, Murdock RH, Morrill BB, Sue SO. Ranitidine 300\u00a0mg twice daily and 150\u00a0mg four-times daily are effective in healing erosive oesophagitis. Aliment Pharmacol Ther. 1996;10:373\u201380.","journal-title":"Aliment Pharmacol Ther"},{"key":"283_CR24","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1023\/A:1018822532736","volume":"43","author":"ML Cloud","year":"1998","unstructured":"Cloud ML, Enas N, Humphries TJ, Bassion FS. Rabeprazole in the treatment of acid peptic diseases: results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer and gastroesopageal reflux disease (GERD). The Rabeprazole Study Group. Digest Dis Sci. 1998;43:993\u20131000.","journal-title":"Digest Dis Sci"},{"key":"283_CR25","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1111\/j.1572-0241.2000.03254.x","volume":"95","author":"JE Richter","year":"2000","unstructured":"Richter JE, Bochenek W. Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Panatoprazole US GERD Study Group. Am J Gastroenterol. 2000;95:3071\u201380.","journal-title":"Am J Gastroenterol"},{"key":"283_CR26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0016-5085(92)91790-B","volume":"102","author":"SJ Sontag","year":"1992","unstructured":"Sontag SJ, Hirschowitz BI, Holt S, Robinson MG, Behar J, Berenson MM, et al. Two doses of omeprazole versus placebo in symptomatic erosive esophagitis: the US multicenter study. Gastroenterology. 1992;102:109\u201318.","journal-title":"Gastroenterology"},{"key":"283_CR27","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0016-5107(99)70285-3","volume":"49","author":"M Kusano","year":"1999","unstructured":"Kusano M, Ino K, Yamada T, Kawamura O, Toki M, Ohwada T, et al. Interobserver and intraobserver variation in endoscopic assessment of GERD using the \u201cLos Angeles\u201d classification. Gastrointest Endosc. 1999;49:700\u20134.","journal-title":"Gastrointest Endosc"},{"key":"283_CR28","first-page":"48","volume":"10","author":"S Nasseri-Moghaddam","year":"2007","unstructured":"Nasseri-Moghaddam S, Razjouyan H, Nouraei M, Alimohammadi M, Mamarabadi M, Vahedi H, et al. Inter- and intra-observer variability of the Los Angeles classification: a reassessment. Arch Iranian Med. 2007;10:48\u201353.","journal-title":"Arch Iranian Med"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-010-0283-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-010-0283-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-010-0283-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T02:37:50Z","timestamp":1559097470000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-010-0283-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,15]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["283"],"URL":"https:\/\/doi.org\/10.1007\/s00535-010-0283-8","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,15]]}}}